FDA Inspection 1256820 — Innovative Fertility Center
The FDA completed an inspection of Innovative Fertility Center on December 17, 2024 in Manhattan Beach, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 3 citations were issued during this inspection. Product area: Biologics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- December 17, 2024
- Fiscal Year
- 2025
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Manhattan Beach, CA (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 12213 | 21 CFR 1271.47(a) | Testing, screening, donor eligibility procedures |
| 12240 | 21 CFR 1271.55(b)(3) | Name and address on summary |
| 12277 | 21 CFR 1271.75(a)(1) | Risk factors, clinical evidence |